HIV-1 Nef impairs MHC class II antigen presentation and surface expression
- PMID: 11593029
- PMCID: PMC59782
- DOI: 10.1073/pnas.221256498
HIV-1 Nef impairs MHC class II antigen presentation and surface expression
Abstract
HIV-1-infected cells can avoid cytotoxic T lymphocyte killing by Nef-mediated down-regulation of surface MHC I. Here, we show that HIV-1 Nef inhibits MHC II restricted peptide presentation to specific T cells and thus may affect the induction of antiviral immune responses. Nef mediates this effect by reducing the surface level of mature (i.e., peptide-loaded) MHC II while increasing levels of immature MHC II, which are functionally incompetent because of their association with the invariant chain. Nef was the only HIV-1 gene product to possess this capacity, which was also observed in the context of the whole HIV-1 genome. Other proteins of the endocytic pathway were not affected by Nef expression, suggesting that Nef effects on MHC II did not result from a general alteration of the endocytic pathway. Response patterns to previously characterized mutations of Nef differed for Nef-induced modulation of mature and immature MHC II. Furthermore, the doses of Nef required to observe each of the two effects were clearly different, suggesting that Nef could affect MHC II peptide presentation through distinct mechanisms. Cooperation between those mechanisms may enable Nef to efficiently inhibit MHC II function.
Figures
Similar articles
-
Nef alleles from children with non-progressive HIV-1 infection modulate MHC-II expression more efficiently than those from rapid progressors.AIDS. 2007 May 31;21(9):1103-7. doi: 10.1097/QAD.0b013e32816aa37c. AIDS. 2007. PMID: 17502720
-
Modulation of specific surface receptors and activation sensitization in primary resting CD4+ T lymphocytes by the Nef protein of HIV-1.J Leukoc Biol. 2006 Mar;79(3):616-27. doi: 10.1189/jlb.0805461. Epub 2005 Dec 19. J Leukoc Biol. 2006. PMID: 16365153
-
Primary sooty mangabey simian immunodeficiency virus and human immunodeficiency virus type 2 nef alleles modulate cell surface expression of various human receptors and enhance viral infectivity and replication.J Virol. 2005 Aug;79(16):10547-60. doi: 10.1128/JVI.79.16.10547-10560.2005. J Virol. 2005. PMID: 16051847 Free PMC article.
-
Regulation of MHC II and CD1 antigen presentation: from ubiquity to security.J Leukoc Biol. 2009 Feb;85(2):215-24. doi: 10.1189/jlb.0308206. Epub 2008 Sep 22. J Leukoc Biol. 2009. PMID: 18809734 Review.
-
HIV's evasion of the cellular immune response.Immunol Rev. 1999 Apr;168:65-74. doi: 10.1111/j.1600-065x.1999.tb01283.x. Immunol Rev. 1999. PMID: 10399065 Review.
Cited by
-
One protein to rule them all: modulation of cell surface receptors and molecules by HIV Nef.Curr HIV Res. 2011 Oct;9(7):496-504. doi: 10.2174/157016211798842116. Curr HIV Res. 2011. PMID: 22103833 Free PMC article. Review.
-
HIV-1 Nef interferes with T-lymphocyte circulation through confined environments in vivo.Proc Natl Acad Sci U S A. 2012 Nov 6;109(45):18541-6. doi: 10.1073/pnas.1204322109. Epub 2012 Oct 23. Proc Natl Acad Sci U S A. 2012. PMID: 23093676 Free PMC article.
-
A Novel HIV-1 Nef Mutation in a Primary Pediatric Isolate Impairs MHC-Class I Downregulation and Cytopathicity.AIDS Res Hum Retroviruses. 2020 Feb;36(2):122-130. doi: 10.1089/AID.2019.0160. Epub 2019 Nov 4. AIDS Res Hum Retroviruses. 2020. PMID: 31571497 Free PMC article.
-
Human immunodeficiency virus type 1 nef expression prevents AP-2-mediated internalization of the major histocompatibility complex class II-associated invariant chain.J Virol. 2008 Sep;82(17):8373-82. doi: 10.1128/JVI.00670-08. Epub 2008 Jul 2. J Virol. 2008. PMID: 18596106 Free PMC article.
-
HLA-DR+ CD38+ CD4+ T lymphocytes have elevated CCR5 expression and produce the majority of R5-tropic HIV-1 RNA in vivo.J Virol. 2011 Oct;85(19):10189-200. doi: 10.1128/JVI.02529-10. Epub 2011 Aug 3. J Virol. 2011. PMID: 21813616 Free PMC article.
References
-
- Schwartz O, Marechal V, Le Gall S, Lemonnier F, Heard J M. Nat Med. 1996;2:338–342. - PubMed
-
- Le Gall S, Erdtmann L, Benichou S, Berlioz-Torrent C, Liu L, Benarous R, Heard J M, Schwartz O. Immunity. 1998;8:483–495. - PubMed
-
- Collins K L, Chen B K, Kalams S A, Walker B D, Baltimore D. Nature (London) 1998;391:397–401. - PubMed
-
- Cohen G B, Gandhi R T, Davis D M, Mandelboim O, Chen B K, Strominger J L, Baltimore D. Immunity. 1999;10:661–671. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
